Reliable Genotypic Tropism Tests for the Major HIV-1 Subtypes

Over the past decade antiretroviral drugs have dramatically improved the prognosis for HIV-1 infected individuals, yet achieving better access to vulnerable populations remains a challenge. The principal obstacle to the CCR5-antagonist, maraviroc, from being more widely used in anti-HIV-1 therapy re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Cashin, Kieran, Gray, Lachlan R., Harvey, Katherine L., Perez-Bercoff, Danielle, Lee, Guinevere Q., Sterjovski, Jasminka, Roche, Michael, Demarest, James F., Drummond, Fraser, Harrigan, P. Richard, Churchill, Melissa J., Gorry, Paul R.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4894445/
https://ncbi.nlm.nih.gov/pubmed/25712827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep08543
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars